Metastatic breast cancer causes death primarily through organ failure, as tumors spread to the liver, lungs, brain, or bones and disrupt those organs’ ability to function. About 83% of people with metastatic breast cancer die from the cancer itself, while the remaining 17% die from cardiovascular disease, infections, blood clots, or other competing causes. The specific way the disease becomes fatal depends heavily on where it spreads and how the body responds to that burden.
How Organ Metastases Lead to Failure
Breast cancer cells can settle in almost any organ, but the liver, lungs, brain, and bones are the most common destinations. Each site creates a different path toward life-threatening complications, and many patients have metastases in more than one location at the same time.
Liver
When breast cancer spreads extensively to the liver, it can replace enough healthy tissue to cause liver failure. This typically unfolds over two to six weeks with fatigue, nausea, loss of appetite, jaundice, and fluid buildup in the abdomen. As liver function deteriorates, the organ can no longer filter toxins from the blood, leading to confusion and altered consciousness. Clotting ability drops, making bleeding harder to control. One of the cruelest aspects of liver metastases is that they can prevent treatment from continuing: the liver processes most chemotherapy drugs, and when it’s too damaged to do so safely, options narrow significantly. In severe cases, the cascade progresses to multi-organ failure.
Lungs
Lung metastases cause death through progressive respiratory failure. Tumors growing in lung tissue reduce the surface area available for oxygen exchange, leaving less and less capacity for breathing. Many patients also develop pleural effusions, where fluid collects between the lung and chest wall, compressing the lung further. This fluid can be drained, but it often reaccumulates, creating a cycle of worsening breathlessness. The underlying mechanisms include increased strain on the muscles used for breathing, restricted airflow, and the body’s rising demand for oxygen that the damaged lungs can no longer meet.
Brain
Brain metastases create danger both from the tumors themselves and from the swelling they trigger in surrounding tissue. Because the skull is rigid, any growth inside it raises pressure, which can cause headaches, seizures, cognitive changes, weakness on one side of the body, and personality shifts. As tumors grow or swelling worsens, the pressure can become severe enough to compress the brainstem, which controls basic functions like breathing and heart rate. This compression, called herniation, is one of the most acute causes of death in brain metastases.
Bones
Bone metastases rarely cause death directly through structural damage, but they trigger a dangerous metabolic complication: hypercalcemia. As cancer breaks down bone tissue, calcium floods the bloodstream. High calcium levels disrupt the heart’s electrical rhythm, impair kidney function, cause severe confusion, and can lead to cardiac arrest. The prevalence of hypercalcemia in metastatic breast cancer more than doubled between 1999 and 2014, and despite improvements in overall hospital survival rates, hypercalcemia still carries an independent and significant risk of death.
Cachexia and Whole-Body Decline
Cancer cachexia is a wasting syndrome that goes far beyond simply not eating enough. It’s thought to directly cause up to 30% of cancer deaths, often through heart or respiratory failure tied to severe muscle loss. The process is driven by widespread inflammation: chemical messengers released by both the tumor and the immune system disrupt normal metabolism, causing muscle and fat to break down far faster than the body can rebuild them. This creates a vicious cycle. The inflammation also suppresses appetite, robbing the body of fuel at the very moment it needs more. Over time, the loss of skeletal muscle weakens the diaphragm and the heart muscle itself, making both breathing and circulation increasingly fragile. Cachexia can be the final common pathway even when no single organ metastasis is immediately fatal.
Blood Clots as a Hidden Threat
People with metastatic breast cancer face a significantly elevated risk of blood clots, particularly pulmonary embolism, where a clot blocks blood flow to the lungs. Among cancer patients receiving chemotherapy outside the hospital, roughly 3% of deaths are caused by pulmonary embolism. For those who are hospitalized, that figure rises to 10%. Cancer increases clotting risk through several overlapping mechanisms: tumors release substances that activate the clotting cascade, chemotherapy damages blood vessel walls, and immobility from illness or treatment compounds the problem. A large pulmonary embolism can cause sudden cardiovascular collapse with little warning.
Infections and Immune Vulnerability
Advanced cancer and its treatments both suppress the immune system, making infections a persistent and sometimes fatal threat. Pneumonia is the most common infectious cause of death in breast cancer patients. Chemotherapy reduces white blood cell counts, leaving the body poorly equipped to fight bacteria, viruses, and fungi. Patients with liver metastases face additional risk because the liver plays a central role in immune function. Infections can escalate rapidly to sepsis, a body-wide inflammatory response that causes blood pressure to drop and organs to fail in sequence.
Cardiovascular Causes
Cardiovascular disease is the second leading cause of death among breast cancer patients overall, after the cancer itself. In one large population-based study, cardiovascular deaths included strokes, chronic heart disease, high blood pressure complications, and heart attacks. Some of this risk comes from the treatments themselves. Certain chemotherapy regimens and radiation to the left chest can damage the heart muscle or accelerate artery disease. Combined with the cardiac strain from cachexia-related muscle loss and the metabolic stress of advanced illness, the cardiovascular system can become a point of failure even when the cancer itself appears stable.
How Survival Varies by Cancer Type
Not all metastatic breast cancers progress at the same rate, and the cause of death often correlates with the cancer’s biology. A real-world study of 1,000 patients treated between 2014 and 2022 found a median overall survival of about 32 months from diagnosis of metastatic disease. But the range was wide. HER2-positive cancers had the longest median survival at 42 months, followed by hormone receptor-positive cancers at 39 months. More aggressive subtypes fared worse: 21 months for luminal B-like cancers, and 14 months for triple-negative breast cancer.
These differences matter because slower-growing cancers give the body more time to develop complications like cachexia or cardiovascular disease, while aggressive cancers are more likely to cause rapid organ failure. Triple-negative breast cancer, for instance, is more likely to metastasize to the brain and internal organs early, leading to acute organ crises rather than gradual decline.
The Overlap of Multiple Causes
In practice, death from metastatic breast cancer is rarely caused by a single clean mechanism. A patient with liver metastases may develop an infection their immune system can’t fight. Someone with bone metastases may experience hypercalcemia that triggers a fatal heart rhythm. Cachexia weakens the heart and breathing muscles while lung metastases reduce oxygen supply. The final cause of death is typically the point where these overlapping stresses exceed what the body can compensate for, a tipping point that can arrive gradually or suddenly depending on which organs are involved and how quickly the disease is progressing.